SORT1 and multiple sclerosis: Due to the immunomodulatory and anti-inflammatory properties of NT-3, and its possibility to induce regeneration and myelination, currently NT-3- based AAV1-gene therapy of multiple sclerosis is under investigation in a mice model [88].